e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Basic science in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expression of ADAM 33 in an equine model of asthma
M. Riihimaki, J. Pringle, J. Pourazar, T. Sandstrom, T. Art, P. Lekeux, L. Couetil, A. Raine (Uppsala, Umea, Sweden; Liege, Belgium; West Lafayette, IN, United States Of America)
Source:
Annual Congress 2008 - Basic science in asthma and COPD
Session:
Basic science in asthma and COPD
Session type:
Thematic Poster Session
Number:
3579
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Riihimaki, J. Pringle, J. Pourazar, T. Sandstrom, T. Art, P. Lekeux, L. Couetil, A. Raine (Uppsala, Umea, Sweden; Liege, Belgium; West Lafayette, IN, United States Of America). Expression of ADAM 33 in an equine model of asthma. Eur Respir J 2008; 32: Suppl. 52, 3579
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Role of CD163 in human fatal asthma and murine asthma model.
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
ADAM 33 in embryonic airways
Source: Eur Respir J 2005; 26: Suppl. 49, 223s
Year: 2005
Expression of PLUNC proteins in asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
ADAM 33 as a key susceptibility gene for asthma: the contribution of this novel protease to disease pathogenesis
Source: Annual Congress 2003 - Proteases at the cutting edge of respiratory disease
Year: 2003
Mapping a mouse model of severe asthma to human asthma using gene set variation analysis
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Metalloproteinase 9 and TIMIP expression in large airways of fatal asthma
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Year: 2007
Decreased Smad7 expression in the airways of a mouse model of chronic asthma
Source: Annual Congress 2004 - Animal models of allergic airway disease
Year: 2004
Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002
Role of mouse mast cell protease 4 in a murine model of allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Angiopoietin 1 expression is reduced in a mouse model of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006
Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of human respiratory syncytial virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Intratracheally administered recombinant adenovirus carrying a novel mutated IκBα gene abrogates pulmonary eosinophil inflammation in a murine asthma model
Source: Eur Respir J 2006; 28: Suppl. 50, 225s
Year: 2006
Matrix metalloproteinase 2 expression in distal lung of fatal asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 549s
Year: 2006
Members of the microRNA cluster 17-92 are disease specifically regulated in fibroblasts of idiopathic pulmonary fibrosis
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
Microarrays reveal coordinated expression of ADAMs family of genes in an
in vitro
model of pulmonary fibrosis
Source: Annual Congress 2005 - Progresses in lung fibrosis
Year: 2005
Influence of CpG-oligodeoxynucleotides and dexamethasone on remodeling and expression of MMP-9 in murine model of chronic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 224s
Year: 2006
Characterisation and mRNA expression analysis of the bronchial hyperresponsiveness susceptibility gene protocadherin-1 in asthma patients
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Metalloproteinase 1 expression in distal lung of fatal asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Year: 2005
-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Murine models of asthma
Source: Guideline 2003
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept